The Effect of a Multi-modal Program on Fear of Cancer Recurrence in Breast Cancer Patients

Launched by LIU WEIMIN · Mar 16, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a special program called the Multi-modal Program (MMP) to see if it can help breast cancer patients feel less anxious about their cancer coming back, manage their symptoms better, and improve their social support. The researchers want to find out if patients who participate in this program experience significant improvements compared to those who only receive standard care during their chemotherapy treatment.

To be eligible for this trial, participants must be at least 18 years old, currently diagnosed with breast cancer, and undergoing chemotherapy. They should be able to communicate clearly and understand their diagnosis. The trial will involve participating in the program once during each chemotherapy cycle for eight weeks. Throughout the study, researchers will measure feelings of anxiety about cancer recurrence, cancer symptoms, and the level of social support participants have at the start, eight weeks later, and again twelve weeks after the program ends. This research aims to provide helpful insights for improving the care and support of breast cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis meets the criteria outlined in the Breast Cancer Diagnosis and Treatment Guidelines, with a pathological diagnosis of breast cancer and currently undergoing chemotherapy
• • Age ≥ 18 years
• • Clear consciousness and the ability to communicate independently
• • Aware of the diagnosis and has signed the informed consent form
• Exclusion Criteria:
• • Presence of mental illness or cognitive impairment
• • Hearing or speech impairmen
• • Distant metastasis of cance
• • Severe physical illness or other malignant tumors requiring treatment